Transcriptional Activation and Increased MRNA Stability Contribute to Overexpression of CDR1 in Azole-resistant Candida Albicans

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2008 Feb 13

PMID 18268086

Citations 23

Authors

Raman Manoharlal

Naseem Akhtar Gaur

Sneh Lata Panwar

Joachim Morschhauser

Rajendra Prasad

Affiliations

Soon will be listed here.

Abstract

Many azole-resistant (AR) clinical isolates of Candida albicans display increased expression of the drug transporters CDR1 and CDR2. In this study, we evaluate the molecular mechanisms that contribute to the maintenance of constitutively high CDR1 transcript levels in two matched pairs of azole-susceptible (AS) and AR clinical isolates of C. albicans. To address this, we use reporter constructs of GFP and lacZ fused either to the CDR1 promoter (P CDR1-GFP/lacZ; transcriptional fusion) or to the CDR1 open reading frame (P CDR1-CDR1-GFP/lacZ; translational fusion) integrated at the native CDR1 locus. It is observed that expression of the two reporter genes as a transcriptional fusion in the AR isolates is higher than that in matched AS isolates. However, the difference in the reporter activity between the AS and AR isolates is even greater for the translational fusions, indicating that the sequences within the CDR1 coding region also contribute to its increased expression in AR isolates. Further analysis of these observations by transcription run-on assays demonstrated a approximately 5- to 7-fold difference in the transcription initiation rates for the AR isolates from those for their respective matched AS isolates. Measurement of mRNA stability showed that the half-life of CDR1 mRNA in the AR isolates was threefold higher than that in the corresponding AS isolates. Our results demonstrate that both increased CDR1 transcription and enhanced CDR1 mRNA stability contribute to the overexpression of CDR1 in AR C. albicans isolates.

Citing Articles

Cdr1 in focus: a personal reflection on multidrug transporter research.

Prasad R FEMS Yeast Res. 2025; 25.

PMID: 39883094 PMC: 11781190. DOI: 10.1093/femsyr/foaf003.

Fungal Drug Response and Antimicrobial Resistance.

Osset-Trenor P, Pascual-Ahuir A, Proft M J Fungi (Basel). 2023; 9(5).

PMID: 37233275 PMC: 10219139. DOI: 10.3390/jof9050565.

Structural Characterization, Cytotoxicity, and the Antifungal Mechanism of a Novel Peptide Extracted from Garlic ( L.).

Li S, Wang Y, Zhou J, Wang J, Zhang M, Chen H Molecules. 2023; 28(7).

PMID: 37049861 PMC: 10095746. DOI: 10.3390/molecules28073098.

Development and applications of a CRISPR activation system for facile genetic overexpression in Candida albicans.

Gervais N, La Bella A, Wensing L, Sharma J, Acquaviva V, Best M G3 (Bethesda). 2022; 13(2).

PMID: 36450451 PMC: 9911074. DOI: 10.1093/g3journal/jkac301.

Post-transcriptional control of antifungal resistance in human fungal pathogens.

Sharma C, Kadosh D Crit Rev Microbiol. 2022; 49(4):469-484.

PMID: 35634915 PMC: 9766424. DOI: 10.1080/1040841X.2022.2080527.

References

Lopez-Camarillo C, Luna-Arias J, Marchat L, Orozco E . EhPgp5 mRNA stability is a regulatory event in the Entamoeba histolytica multidrug resistance phenotype. J Biol Chem. 2003; 278(13):11273-80. DOI: 10.1074/jbc.M211757200. View

Kimchi-Sarfaty C, Oh J, Kim I, Sauna Z, Calcagno A, Ambudkar S . A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2006; 315(5811):525-8. DOI: 10.1126/science.1135308. View

Coste A, Karababa M, Ischer F, Bille J, Sanglard D . TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell. 2004; 3(6):1639-52. PMC: 539021. DOI: 10.1128/EC.3.6.1639-1652.2004. View

Krishnamurthy S, Gupta V, Panwar S, Prasad R . Expression of CDR1, a multidrug resistance gene of Candida albicans: transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Microbiol Lett. 1998; 160(2):191-7. DOI: 10.1111/j.1574-6968.1998.tb12910.x. View

Li D, Gurkovska V, Sheridan M, Calderone R, Chauhan N . Studies on the regulation of the two-component histidine kinase gene CHK1 in Candida albicans using the heterologous lacZ reporter gene. Microbiology (Reading). 2004; 150(Pt 10):3305-13. DOI: 10.1099/mic.0.27237-0. View

Wirsching S, Michel S, Kohler G, Morschhauser J . Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol. 2000; 182(2):400-4. PMC: 94289. DOI: 10.1128/JB.182.2.400-404.2000. View

Prasad R, de Wergifosse P, Goffeau A, Balzi E . Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet. 1995; 27(4):320-9. DOI: 10.1007/BF00352101. View

Lopez-Ribot J, McAtee R, Lee L, Kirkpatrick W, White T, Sanglard D . Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother. 1998; 42(11):2932-7. PMC: 105968. DOI: 10.1128/AAC.42.11.2932. View

Wang D, Johnson A, Papp A, Kroetz D, Sadee W . Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics. 2005; 15(10):693-704. View

10.

Puri N, Krishnamurthy S, Habib S, Hasnain S, Goswami S, Prasad R . CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole. FEMS Microbiol Lett. 1999; 180(2):213-9. DOI: 10.1111/j.1574-6968.1999.tb08798.x. View

11.

Yang Y, Lin Y, Tsao M, Chen C, Shih H, Fan J . Serum repressing efflux pump CDR1 in Candida albicans. BMC Mol Biol. 2006; 7:22. PMC: 1543648. DOI: 10.1186/1471-2199-7-22. View

12.

Uhl M, Johnson A . Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans. Microbiology (Reading). 2001; 147(Pt 5):1189-1195. DOI: 10.1099/00221287-147-5-1189. View

13.

Franz R, Ruhnke M, Morschhauser J . Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses. 1999; 42(7-8):453-8. DOI: 10.1046/j.1439-0507.1999.00498.x. View

14.

Nieto A, Perez D, Orozco E, Paz F, Gomez C . Entamoeba histolytica EhPgp5 transcriptional activation depends on putative emetine response elements. Exp Parasitol. 2005; 110(3):233-7. DOI: 10.1016/j.exppara.2005.03.016. View

15.

de Micheli M, Bille J, Schueller C, Sanglard D . A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol. 2002; 43(5):1197-214. DOI: 10.1046/j.1365-2958.2002.02814.x. View

16.

Gaur N, Puri N, Karnani N, Mukhopadhyay G, Goswami S, Prasad R . Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene CDR1 of Candida albicans. FEMS Yeast Res. 2004; 4(4-5):389-99. DOI: 10.1016/S1567-1356(03)00204-6. View

17.

Karnani N, Gaur N, Jha S, Puri N, Krishnamurthy S, Goswami S . SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter. Yeast. 2004; 21(3):219-39. DOI: 10.1002/yea.1067. View

18.

Haque A, Rai V, Bahal B, Shukla S, Lattif A, Mukhopadhyay G . Allelic variants of ABC drug transporter Cdr1p in clinical isolates of Candida albicans. Biochem Biophys Res Commun. 2006; 352(2):491-7. DOI: 10.1016/j.bbrc.2006.11.035. View

19.

Akins R . An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol. 2005; 43(4):285-318. DOI: 10.1080/13693780500138971. View

20.

Gaur N, Manoharlal R, Saini P, Prasad T, Mukhopadhyay G, Hoefer M . Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element. Biochem Biophys Res Commun. 2005; 332(1):206-14. DOI: 10.1016/j.bbrc.2005.04.113. View